2019
 
2015
2016
2017
2018
2019
 
2019
 


My subsidiary won Funding of Technology Transfer
 
Jul. 29th, 2019—Nanjing, China--Adhering to the "Innovation as dynamics, differentiation as core" business philosophy and being committed to providing differentiated products with intellectual property solutions and environmentally friendly chemical technology to global customers by comprehensive research and development capabilities, Nanjing F&S PharmaTech Co., Ltd. (hereinafter referred to as F&S) announced that Nanjing Yaoshenghe Pharmatech Co., Ltd. (hereinafter referred to as Nanjing Yaoshenghe),the holding subsidiary of F&S, won Nanjing Funding of Technology Transfer in differentiated generic drug project under development. 

F&S signed an agreement with Nanjing Branch of The People's Insurance Company of China (hereinafter referred to as PICC) in May, 2019. We insured the differentiated generic drug in Nanjing Yaoshenghe through PICC, which is also the first insurance business for the loss of R&D costs of scientific and technological projects due to uncertainty in the R&D process.  

About Nanjing Funding of Technology Transfer
Set up to vitalize technology transfer and promote the transfer of scientific and technological achievements, which is on the basis of the spirit of Nanjing Municipal Committee Document No.1 in 2018 and 2019 and the relevant provision of “Rules for the Implementation to Establish Funding of Technology Transfer”.

Nanjing Yaoshenghe Pharmatech Co., Ltd.
Jointly initiated by F&S and Shanghai Unionlab Co., Ltd. in June 2018 Nanjing. Combining the complementary advantages of both sides and the advantage of policy, the aim is to work together on R&D and commercial production of differentiated products and make effort to bring good medicines for people earlier.

About Nanjing F&S Pharmatech Co., Ltd.
Founded in Oct. 2015 and has completed three rounds of financing, which won National High-tech Enterprise, Fostering Unicorn Enterprises in Nanjing and the first batch of "Little Lark" Enterprises in Jiangbei New Area of Nanjing. We have 5000 square meters of R&D center and have established a comprehensive in-depth cooperation with Jiangsu Yongda Pharmaceutical Co., Ltd.
For more information of Nanjing F&S Pharmatech Co., Ltd., please visit company website: www.fshpharm.com.

 
 
Copyright © 2014-2015 DEDECMS 方生和医药科技有限公司 版权所有
网站开发:希丁哥